GUYER WILLIAM (Chief Development Officer) sold 78.7% of their position (8.23K shares) of CORCEPT THERAPEUTICS INC on the open market
Open‑market sale worth $296.3K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 3/6/2026ACC: 0001193125-26-096653
Officer· Chief Development Officer
Since Aug 2021
-8.23K
Net shares
Net seller
$296.3K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
8.23K acquired · 16.47K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+8.23K
Price / share
$21.65
Trade value
$178.24K
% of position
369.0%
3/4/2026
2.23K→10.46K
Common Stock
Direct
Shares
−8.23K
Price / share
$35.99
Trade value
$296.35K
% of position
78.7%
3/4/2026
10.46K→2.23K
Total
Net shares
+0.00
Net value
-$118.10K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/4/2026 | M · Option Exercise | +8.23K | $21.65 | $178.24K | 369.0% | 2.23K | 10.46K |
| Common Stock Direct | 3/4/2026 | S · Sale | −8.23K | $35.99 | $296.35K | 78.7% | 10.46K | 2.23K |
| Total | +0.00 | -$118.10K | ||||||
Derivative Transactions1
Stock Option (right to buy)
Direct
Converts to
Common Stock
8.23K shares
Shares
−8.23K
Strike price
21.65
Held after
221.77K
Exercisable
—
3/4/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock8.23K shares | 3/4/2026 | M · Option Exercise | −8.23K | 21.65 | — | 221.77K |